Patents by Inventor Andrew R. Hilgenbrink

Andrew R. Hilgenbrink has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of imaging osteoarthritis using a folate conjugate
    Patent number: 9731035
    Abstract: The invention relates to a method of treating or diagnosing a disease state mediated by monocytes. The method utilizes a composition comprising a conjugate or complex of the general formula Ab-X wherein the group Ab comprises a ligand that binds to monocytes, and when the conjugate is being used for treatment of the disease state, the group X comprises an immunogen, a cytotoxin, or a compound capable of altering monocyte function, and when the conjugate is being used for diagnosing the disease state, the group X comprises an imaging agent.
    Type: Grant
    Filed: March 11, 2013
    Date of Patent: August 15, 2017
    Assignee: Purdue Research Foundation
    Inventors: Philip S. Low, Andrew R. Hilgenbrink
  • Imaging and Therapeutic Method Using Monocytes
    Publication number: 20090214636
    Abstract: The invention relates to a method of treating or diagnosing a disease state mediated by monocytes. The method utilizes a composition comprising a conjugate or complex of the general formula Ab-X wherein the group Ab comprises a ligand that binds to monocytes, and when the conjugate is being used for treatment of the disease state, the group X comprises an immunogen, a cytotoxin, or a compound capable of altering monocyte function, and when the conjugate is being used for diagnosing the disease state, the group X comprises an imaging agent.
    Type: Application
    Filed: February 24, 2009
    Publication date: August 27, 2009
    Inventors: Philip S. Low, Andrew R. Hilgenbrink